City State Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

City State Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.5K	Hold	160	–	–	0.02%	309
2026 Q1	$71.4K	Hold	160	–	–	0.02%	306
2025 Q4	$72.5K	Hold	160	–	–	0.02%	306
2025 Q3	$62.7K	Buy	160 +50	+45%	+$20.9K	0.02%	314
2025 Q2	$49K	Hold	110	–	–	0.02%	341
2025 Q1	$53.3K	Buy	110 +97	+746%	+$45.2K	0.02%	325
2024 Q4	$5.24K	Sell	13 -25	-66%	-$11.6K	﹤0.01%	569
2024 Q3	$17.7K	Hold	38	–	–	0.01%	444
2024 Q2	$17.8K	Sell	38 -12	-24%	-$5.21K	0.01%	423
2024 Q1	$21K	Sell	50 -25	-33%	-$10.6K	0.01%	407
2023 Q4	$31K	Hold	75	–	–	0.02%	350
2023 Q3	$26K	Hold	75	–	–	0.01%	356
2023 Q2	$26K	Hold	75	–	–	0.01%	364
2023 Q1	$24K	Hold	75	–	–	0.01%	360
2022 Q4	$22K	Hold	75	–	–	0.01%	358
2022 Q3	$22K	Hold	75	–	–	0.02%	344
2022 Q2	$21K	Hold	75	–	–	0.01%	347
2022 Q1	$20K	Hold	75	–	–	0.01%	376
2021 Q4	$16K	Buy	+75	New	+$14.6K	0.01%	413

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

City State Bank's VRTX Position: Q2 2026 in Review

City State Bank held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 160 shares worth $79.5K. The position accounts for 0.02% of the portfolio, ranked #309.

City State Bank first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

City State Bank held 160 shares of Vertex Pharmaceuticals worth $79.5K as of Q2 2026.
City State Bank left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of City State Bank's portfolio in Q2 2026, its #309 holding.
City State Bank first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.